(R)-2-phenyl-2-((R)-piperidin-2-yl)acetic acid-d5 (TFA)

(R)-2-phenyl-2-((R)-piperidin-2-yl)acetic acid-d5 (TFA)

• UNSPSC Description: (R)-2-phenyl-2-((R)-piperidin-2-yl)acetic acid-d5 (D-threo-Ritalinic Acid-d5) TFA is deuterium-labeled (R)-2-phenyl-2-((R)-piperidin-2-yl)acetic acid (HY-W422491)[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: others
• Smiles: O=C(O)[C@H](C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H])[C@@H]2NCCCC2.FC(F)(C(O)=O)F
• Molecular Weight: 338.33
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133(3): 366-391.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported